ACCO is excited to inform our constituency that the U.S. House of Representatives today approved the 21st Century Cures Act, by a vote of 392-26. This important legislation includes $4.8 billion supplemental funding for the NIH over the next 10 fiscal years, including $1.8 billion in funding over the next seven fiscal years for the cancer “Moonshot” initiative; an additional $500 million to the FDA over 10 years to move drugs more quickly to patients while maintaining safety and efficacy and reauthorization of the Creating Hope Act until 2020 – a voucher program to enhance drug development for rare pediatric diseases including childhood cancer! The legislation is scheduled to be considered by the Senate next week, with passage considered to be highly likely. A summary of the legislation prepared by the House Rules Committee can be found here: Download Now
“We are on the cusp of something special — a once-in-a-generation opportunity to transform how we treat disease,” said Representative Fred Upton (R-Mich.), who marshaled the legislation through the House. “With today’s vote, we are taking a giant leap on the path to cures.” Read More
For additional information about childhood cancer or on the ACCO, or to order resources for you or your child, please visit our website at www.acco.org , call 855.858.2226 or visit:
Want To Read American Childhood Cancer Organization On Your Phone? Click the NoteStream logo: 